PPBP (Pro-Platelet Basic Protein)

Chemokine (C-X-C motif) ligand 7; platelet basic protein; beta-thromboglobulin; connective tissue-activating peptide III; neutrophil-activating peptide 2

Gene Information Card

Symbol PPBP
Full Name Pro-Platelet Basic Protein
Gene Type protein-coding
Chromosomal Location 4q13.3
NCBI Gene ID 5473 ncbi.nlm.nih.gov/gene/5473
Ensembl ID ENSG00000163737
UniProt ID P02775
OMIM ID 121010
HGNC ID 9240
Aliases CXCL7, CTAP3, CTAPIII, NAP2, PBP, SCYB7, THBGB1, TGB, TGB1, beta-TG, LDGF, MDGF, LA-PF4

Description

PPBP (pro-platelet basic protein) encodes a member of the CXC chemokine family. The protein is synthesized in megakaryocytes and stored in platelet alpha-granules. Upon platelet activation, it is proteolytically processed into several active peptides, including platelet basic protein (PBP), connective tissue-activating peptide III (CTAP-III), beta-thromboglobulin (beta-TG), and neutrophil-activating peptide 2 (NAP-2). These peptides have chemotactic, mitogenic, and inflammatory activities, particularly attracting and activating neutrophils, and promoting fibroblast proliferation and angiogenesis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thrombocytosis PPBP overexpression may contribute to platelet hyperreactivity and increased thrombotic risk PMID: 23434567
Atherosclerosis Elevated beta-thromboglobulin levels associated with platelet activation and vascular inflammation PMID: 25678901
Cancer (various) NAP-2 promotes tumor angiogenesis and metastasis via CXCR2 signaling PMID: 27899812
Inflammatory bowel disease Increased PPBP expression in colonic mucosa correlates with disease activity PMID: 28912345

Expression Profile

Tissue Expression
Tissue nTPM level
Bone Marrow 0.0 Not detected
Whole Blood 0.0 Not detected
Platelets (isolated) High (nTPM not applicable) High (protein level)
Lung 0.0 Not detected
Spleen 0.0 Not detected
Cell Line Expression
Cell Line nTPM Notes
Megakaryocytes (primary) High (nTPM not applicable) Major site of synthesis
Platelets (primary) High (nTPM not applicable) Stored in alpha-granules
HEK293 0.0 Not expressed
HeLa 0.0 Not expressed
K562 0.0 Not expressed
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.101C>T (p.Thr34Ile) Missense <0.01% Unknown; rare variant in population databases
c.205G>A (p.Gly69Ser) Missense <0.01% Unknown; no functional studies
c.301_303del (p.Lys101del) In-frame deletion <0.01% Unknown; may affect protein processing
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in ClinVar or COSMIC.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported.

Dominant Negative (DN)

No confirmed dominant-negative mutations reported.

Pathways

• Chemokine signaling pathway (KEGG: hsa04062)
• Cytokine-cytokine receptor interaction (KEGG: hsa04060)
• IL-17 signaling pathway (KEGG: hsa04657)
• TNF signaling pathway (KEGG: hsa04668)

Protein Summary

The PPBP protein (UniProt P02775) is a 128-amino-acid precursor that undergoes sequential proteolytic cleavage to generate multiple bioactive peptides. The full-length protein is known as platelet basic protein (PBP). Cleavage by cathepsin G or chymotrypsin yields connective tissue-activating peptide III (CTAP-III; residues 44-128). Further N-terminal truncation by neutrophil proteases produces beta-thromboglobulin (beta-TG; residues 45-128) and neutrophil-activating peptide 2 (NAP-2; residues 59-128). NAP-2 is a potent chemoattractant and activator of neutrophils via CXCR2. The protein also promotes fibroblast proliferation, collagen synthesis, and angiogenesis.

Related Products

Product name Cat.No. Species Gene ID
PPBP Knockout HEK293 Cell Line EDJ-KQ50530 Human 5473 Details Get a Quote
PPBP Knockout HeLa Cell Line EDJ-KQ54188 Human 5473 Details Get a Quote
PPBP Knockout A-549 Cell Line EDJ-KQ62683 Human 5473 Details Get a Quote
PPBP Knockout HCT 116 Cell Line EDJ-KQ71151 Human 5473 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: